Clinical Trial Update: Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment

View source ↗

Summary

A clinical trial update evaluating blood TB DNA as a biomarker to monitor tuberculosis treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrapulmonary Tuberculosis
• Pulmonary Tuberculosis
• Tuberculosis

Snippet

Sponsor: University of Oxford | Conditions: Mycobacterium Tuberculosis, Tuberculosis, Pulmonary | Status: RECRUITING